BACE Hopes Finally Fizzle As Biogen/Eisai End Elenbecestat Alzheimer's Studies

 
• By Mandy Jackson
alzheimer's disease on MRI - Image
Elenbecestat was the last BACE inhibitor left in clinical trials. • Source: Shutterstock

More from Clinical Trials

More from R&D